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Background: Calprotectin consists of the Ca2+-binding proteins S100a8 and S100a9 that are induced in epithelial
cells in response to tissue damage and infection. Both proteins are also secreted by activated innate immune cells
and numerous studies demonstrate their crucial role in pathological conditions of acute and chronic inflammation.
Results: Here, we established a conditional mouse model with simultaneous S100a8 and S100a9 transgene
expression in hepatocytes (TgS100a8a9hep) under the control of doxycycline to unravel the role of epithelial-derived
Calprotectin on tissue homeostasis and inflammation. TgS100a8a9hep mice displayed a significant enrichment of
neutrophils in peripheral blood and tissues with high blood content. Interestingly, Cxcl1 transcription was
significantly induced in the liver of TgS100a8a9hep mice and primary hepatocytes derived thereof as compared to
Control mice, accompanied by an increase of Cxcl1 serum levels. However, expression of other chemokines with a
known function in neutrophil mobilization from the bone marrow, e.g. Csf3 and Cxcl2, was not altered. Doxycycline
treatment of TgS100a8a9hep mice reduced Cxcl1 expression in the liver and resulted in normal numbers of
neutrophils.
Conclusion: In summary, our data demonstrate for the first time that hepatocyte-specific S100a8 and S100a9
expression induces a systemic mobilization of neutrophils by a specific activation of Cxcl1 transcription in the liver.
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S100 proteins are a family of small Ca2+-binding pro-
teins [1] which share a broad spectrum of functions in-
cluding regulation of enzyme activity, Ca2+-homeostasis,
and interaction with components of the cytoskeleton.
Belonging to this family, S100A8 and S100A9 also
known as migration inhibitory factor-related protein 8
(MRP8) and 14 (MRP14) are low molecular weight pro-
teins of 8 kDa and 14 kDa, respectively, and were ini-
tially described as proteins expressed and released by* Correspondence: j.hess@dkfz-heidelberg.de
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reproduction in any medium, provided the orinfiltrating phagocytes [2,3]. S100A8 and S100A9 form
preferably heterodimers also known as Calprotectin
(S100A8/A9) whereas monomers and homodimers could
not be detected in isolated granulocytes and monocytes
[4]. Although expression of S100A8/A9 under physio-
logic conditions is restricted to cells of myeloid origin
including circulating neutrophils, monocytes, and eosi-
nophils [5,6], strong induction of S100A8/A9 was
detected in epithelial and endothelial cells under inflam-
matory and stress conditions [7]. Furthermore, marked
expression of S100A8/A9 was found in many tumors of
epithelial origin including lung, breast, gastric, colorectal
and prostate cancer [8]. These data strongly imply im-
portant functions of S100A8/A9 under conditions of tis-
sue damage and inflammation. Accordingly S100A8/A9
is strongly induced in a broad variety of different chronic
inflammatory disorders including rheumatoid arthritis,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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brosis, arthritis, and psoriasis [8]. S100A8/A9 is able to
support an inflammatory response via both intra- and
extracellular mechanisms. In fact, intracellular S100A8/
A9 has been shown to facilitate leukocyte trafficking
through the transendothelial membrane via microtubule
reorganization [9], upregulation of CD11b [10], as well
as increase in the binding affinity of CD11b to the endo-
thelial expressed integrin ICAM-1 [11]. Moreover
S100A8/A9 is able to boost the inflammatory response
by promotion of NADPH oxidase activity and produc-
tion of ROS in phagocytes [12] and epithelial cells [13].
After secretion at the site of insult by epithelial and in-
nate immune cells, S100A8/A9 directly acts as a chemo-
attractant for leukocytes, as demonstrated both in vitro
and in vivo [14]. Importantly, S100A8/A9 is known to
amplify pro-inflammatory signals, as it is able to induce
the production and release of many cytokines and che-
mokines by epithelial and innate immune cells, e.g.
CXCL1, CXCL2, IL-6, and TNF [15]. In this context
S100A8/A9 was shown to promote pre-metastatic niche
formation in the lungs of tumor-bearing mice [16,17].
Moreover, S100A8/A9 can promote its own expression
by a feed-forward loop [15].
In vivo studies highlighted a crucial role for S100a8/a9
in the promotion of inflammation [18] and
inflammation-induced carcinogenesis [19] by using
S100a9-/- animals in models of antigen-induced arthritis
and colon carcinogenesis, respectively. However these
studies focused on the role of myeloid-derived S100a8/
a9. In contrast, no causal link between epithelial-derived
S100a8/a9 and the establishment of chronic inflamma-
tion and subsequent tumor-development has been
demonstrated yet. Strong experimental evidence indi-
cates that S100A8/A9 overexpression in hepatocytes is
associated with liver carcinogenesis as epidemiological
studies showed a profound correlation of both proteins
with high grade hepatocellular carcinoma in hu-
mans [20]. Moreover, our group demonstrated a strong
increase in S100a8/a9 in the Mdr2-/- model of
inflammation-induced carcinogenesis in a NF-κB
dependent manner [21]. Interestingly, elevated S100a8/
a9 levels protected hepatocellular carcinoma cell lines
from TNF-mediated apoptosis and promoted the pro-
duction of ROS [21]. Moreover, liver injury induced
by partial hepatectomy lead to induction of S100a8/a9
expression in hepatocytes, suggesting a role in liver re-
generation [22]. Hitherto, we do not know whether
the impact on pathological conditions of liver injury
and carcinogenesis is mediated by well-known functions
of S100a8/a9 on the amplification of pro-inflammatory
signals, including immune cell recruitment and activa-
tion [15,23], because informative in vivo studies are
still missing.In contrast to other in vivo studies focusing on the
function of heavily elevated systemic S100a8/a9 levels in
settings of acute or chronic inflammation [18,24], we
have established a conditional mouse model under the
control of doxycycline to specifically investigate the
effects of local S100a8/a9 overexpression without indu-
cing a pathologic situation. In the present study we show
that the simultaneous expression of S100a8 and S100a9
transgenes in hepatocytes leads to a constant homeo-
static mobilization of neutrophils from the bone marrow
via local induction of Cxcl1 expression. Importantly, the
enrichment of the neutrophils occurs without activation
and therefore hints to a so far unknown mechanism
by which epithelial-derived S100a8/a9 may increase
the surveillance capacity of an organism by innate
immune cells.
Results
Conditional and hepatocyte-specific transgene expression
in TgS100a8a9hep mice
We established a new mouse line (TgS100a8a9hep) with
conditional and hepatocyte-specific co-expression of
S100a8 and S100a9 transgenes by using the Tetracyclin-
inducible expression system (Tet-Off sytem) [25] to in-
vestigate the role of epithelial-derived S100a8/a9 under
conditions of tissue homeostasis as well as pathological
conditions. TgS100a8a9hep mice were generated by
breeding of the hepatocyte-specific transactivator (tTA)
mouse line TALap1 with the TetOa8a9 transgenic
mouse line, containing the Myc/His-tagged S100a8
(tgS100a8) and S100a9 (tgS100a9) transgenes under the
control of a tTA-dependent and bidirectional promoter
(Figure 1A). First, tissue-specific expression of tgS100a8
and tgS100a9 transcripts was confirmed by semi-
quantitative PCR with cDNA from different tissues
derived of TgS100a8a9hep mice. Strong expression of
both transgenes was detected in the liver, while minor
tgS100a9 transcript levels were also found in brain and
adipose tissue, in line with published data on the
TALap1 transgene expression pattern (Figure 1B) [25].
In contrast, back skin, lung, heart, thymus, spleen, kid-
ney, stomach, lymph nodes, and bone marrow displayed
no expression for both transgenes (Figure 1B, Additional
file 1: Figure S1A, data not shown). Quantification of
tgS100a8 and tgS100a9 transcripts in livers from six
month-old TgS100a8a9hep mice by qRT-PCR revealed a
similar expression level compared to younger animals,
demonstrating a persistent transgene expression over
time (Additional file 1: Figure S1B). To confirm condi-
tional transgene expression, TgS100a8a9hep mice were
treated with or without doxycycline for three weeks, and
abolished transgene expression upon doxycycline treat-
ment was measured by qRT-PCR as compared to
control-treated mice (Figure 1C). Finally, expression of
Figure 1 Hepatocyte-specific and conditional S100a8 and S100a9 transgene expression in TgS100a8a9hep mice. (A) Schematic
representation of the transgene construct: the transcriptional transactivator (tTA) is expressed under the control of the hepatocyte-specific
promoter Lap1 (TALap1), binds to and activates the tetracycline operator (TetO), which drives the simultaneous expression of S100a8-myc/his and
S100a9-myc/his transgenes (TetOa8a9). Doxycycline interferes with the binding of tTA to the TetO and inhibits transgene expression. (B) Tissue-
specific tgS100a8 and tgS100a9 expression was determined by semi-quantitative PCR in different tissues from TgS100a8a9hep mice using specific
primers for transgenic S100a8 and S100a9 transcripts. Hprt1 levels served as control for cDNA quantity and quality. (C) TgS100a8a9hep mice were
treated with (+dox) or without (-dox) doxycycline (10 μg/ml) for three weeks and transgene expression was assessed by qRT-PCR using liver
cDNA. The mean value +SD of n=3 animals per group is depicted. (D) Whole liver lysates from a TgS100a8a9hep mouse (dTg) and a single
TetOa8a9 transgenic (sTg) control were purified with an anti-Myc-tag IP Kit and expression of transgenic proteins was monitored by Western blot
analysis using a His-tag specific antibody. HeLa cells were transiently transfected with S100a8 and S100a9 expression vectors and whole cell lysate
was used as a positive control (Co). (E) S100a8/a9 protein was quantified by a heterodimer-specific ELISA in serum of Control (n=7) and
TgS100a8a9hep mice (n=6); mean +SD.
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TgS100a8a9hep but not in Control mice by Western blot
analysis, following enrichment from whole liver lysate
(Figure 1D). However, immunohistochemical (IHC)
staining of liver tissue sections did not show a strong
signal for tgS100a8 and tgS100a9 proteins in hepatocytes
of TgS100a8a9hep mice, whereas S100a8 and S100a9
positive immune cells were easily detectable (data not
shown), suggesting that only minor amounts of trans-
genic proteins were produced. In line with this data, an
S100a8/a9 heterodimer-specific ELISA revealed compar-
able amounts of the S100a8/a9 protein complex in
serum samples of peripheral blood from Control and
TgS100a8a9hep mice (Figure 1E). In summary,
TgS100a8a9hep mice were characterized by a conditional
and tissue-specific transgene expression, which resulted
in a low but persistent tgS100a8 and tgS100a9 proteinlevel in the liver under conditions of normal tissue
homeostasis.
TgS100a8a9hep mice develop a systemic enrichment in
neutrophils
The S100a8/a9 protein complex is associated with in-
flammation [7] especially in the context of leukocyte
chemoattraction and activation [14,26]. To investigate
the impact of transgene expression on normal liver
homeostasis, we analyzed tissue sections from eight
week-old Control and TgS100a8a9hep mice. Staining
with hematoxylin and eosin (HE) revealed no obvious
difference in liver architecture between TgS100a8a9hep
and Control littermates (Figure 2A). Lack of liver dam-
age in response to tgS100a8 and tgS100a9 expression
was further confirmed by similar AST and ALT levels in
serum samples from Control and TgS100a8a9hep mice
Figure 2 Histological characterization of TgS100a8a9hep liver sections. (A) Tissue sections from Control and TgS100a8a9hep mice were stained
with hematoxylin and eosin (HE) or by IHC with specific antibodies for monocytes (F4/80) and granulocytes (Gr1). Representative images from at
least n=5 mice are shown with red staining for F4/80 or Gr1, respectively, and counterstaining with hematoxylin. Bars represent 200 μm. Gr1-
positive (B) and S100a9-positive (C) immune cells from five randomly taken pictures (magnification 50x) from Control (n=9) and TgS100a8a9hep
(n=10) were quantified. Box-plot shows median, 25 % and 75 % quartile (light grey box), 5 % and 95 % percentile (bars), students t-test,
***p≤0.001.
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tochemical staining with anti-HNE antibodies revealed no
sign of increased ROS levels in TgS100a8a9hep as com-
pared to Control livers (Additional file 2: Figure S2C).
Moreover, IHC staining for the monocyte-specific antigen
F4/80 revealed a comparable number of Kupffer cells in
both genotypes (Figure 2A). In contrast, the staining for
Gr1, a marker specific for granulocytes as well as mono-
cytes and myeloid derived suppressor cells (MDSCs), dis-
played a significant increase in Gr1-positive immune cells
in TgS100a8a9hep mice as compared to Control mice
(Figure 2A and B).
IHC staining of liver sections with specific antibodies
for S100a8 and S100a9, respectively, well-characterized
markers for granulocytes and circulating monocytes
[3,27], and subsequent quantification of S100a8 and
S100a9 positive immune cells confirmed a significant in-
crease of this subpopulation of immune cells (Figure 2C,data not shown). Indeed, comparison of the relative
amount of Gr1- and S100a9-positive cells in the liver of
Control and TgS100a8a9hep mice revealed a high correl-
ation coefficient (R2=0.95). Moreover, qRT-PCR analysis
with cDNA of liver samples and primers recognizing se-
lectively endogenous but not transgenic transcripts con-
firmed increased S100a8 and S100a9 expression in
TgS100a8a9hep compared to Control mice (Additional
file 2: Figure S2D). In summary, our data supported a
causal link between transgene expression and the accu-
mulation of a distinct Gr1-positive immune cell subpo-
pulation of the monocyte lineage in the liver of
TgS100a8a9hep mice.
To investigate whether the accumulation of this im-
mune cell subpopulation increased with age or caused
an alteration in liver architecture, liver sections of six
month-old Control and TgS100a8a9hep mice were
stained with HE and for Gr1-positive cells by IHC
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still detectable in liver sections of six month-old
TgS100a8a9hep as compared to Control mice and no ob-
vious difference was found when compared to younger
TgS100a8a9hep animals (Additional file 3: Figure S3).
It is worth mentioning that liver sections of
TgS100a8a9hep mice exhibited an equal distribution of
Gr1-positive cells, suggesting that these cells were not
actively recruited to the liver parenchyma but rather
accumulated in the liver sinusoids due to increased
amounts in the circulating blood. Accordingly, different
tissues from Control and TgS100a8a9hep mice were ana-
lyzed for the expression of endogenous S100a8 and
S100a9 transcripts by qRT-PCR, which was used asFigure 3 Increased amount of neutrophils in peripheral tissue and blo
transcripts was determined by qRT-PCR using cDNA from different tissues o
t-test, *p≤0.05, **p≤0.01, n.s. not significant. (B) Leukocyte subpopulations
were quantified and depicted as relative cell number. Box-plot shows med
**p≤0.01. (C-D) Peripheral blood from Control and TgS100a8a9hep mice (n=
(APC), Gr1 (PE), and Ly-6G (FITC). Graphs show the total percentage of Gr1+
peripheral blood. Box-plot shows median, 25 % and 75 % quartile (light gresurrogate marker for granulocytes. Elevated expression
of endogenous S100a8 transcript was detected in liver,
brain, kidney, and heart from TgS100a8a9hep (n=4) as
compared to Control mice (n=3), whereas the expression
of S100a8 was not altered in spleen, thymus, stomach,
and adipose tissue (Figure 3A). Similar results were mea-
sured for endogenous S100a9 transcript levels by qRT-
PCR (Additional file 4: Figure S4A), indicating a specific
increase in the amount of S100a8/a9 positive immune
cells in highly perfused tissues. In line with this assump-
tion, an almost 2.5-fold enrichment of neutrophils, but
not eosinophils, basophils, monocytes, or lymphocytes
was found in peripheral blood counts of TgS100a8a9hep
as compared to Control mice (n=4, Figure 3B,od samples. (A) Relative expression of endogenous S100a8
f Control (n=3) and TgS100a8a9hep (n=4) mice. Mean +SD, students
in the peripheral blood from Control and TgS100a8a9hep mice (n=4)
ian, 25 % and 75 % quartile (light and dark grey box), students t-test,
7) was subjected to tri-color staining using antibodies against Cd11b
/Ly-6G+ cells (C) and Gr1+/Ly-6G- cells (D) from all Cd11b+ cells in
y box), students t-test, *p≤0.05, n.s. not significant.
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phils were further confirmed by flow cytometric analysis
using an antibody for Ly-6G, a specific marker for neu-
trophils [28,29], in combination with antibodies for
Cd11b and Gr1 to distinguish the neutrophil subpopula-
tion (Cd11b+/Gr1+/Ly-6G+) from other cell types
(Cd11b+/Gr1+/Ly-6G-) including monocytes and mono-
cytic MDSCs [28,30]. The total percentage of Gr1+/Ly-
6G+ neutrophils within the Cd11b+ population was
significantly increased in TgS100a8a9hep as compared to
Control mice (n=7, Figure 3C), whereas the relative
number of the Gr1+/Ly-6G- subpopulation was not
affected by the transgene expression (Figure 3D). To ex-
clude the possibility that Gr1-specific antibodies inter-
fered with binding of anti-Ly-6G to its dedicated
epitope, staining for neutrophils using an antibody spe-
cific for Ly-6C instead of anti-Gr1 was performed on
wild type blood cells. Comparable amount of neutrophils
were found with both staining procedures (Additional
file 4: Figure S4C-E). In summary, our data demonstrate
an age-independent systemic increase of neutrophils in
the circulating blood of TgS100a8a9hep mice, which
resulted in the accumulation of these cells in peripheral
tissues with a strong blood supply, but without obvious
features of inflammation or signs of pathological
condition.
Systemically enriched neutrophils in TgS100a8a9hep mice
are not activated
Since TgS100a8a9hep mice did not develop an obvious
pathological phenotype with age, we investigated the ac-
tivation state of the systemically enriched neutrophil
subpopulation. Upregulation of Mac-1 (Cd11b/Cd18)
and ectodomain shedding of L-Selectin (Cd62L), two fre-
quently used activation markers for neutrophils [31],Figure 4 Molecular markers of neutrophil activation in TgS100a8a9hep
and TgS100a8a9hep mice or isolated neutrophils treated with 10 μg/ml TPA
(APC) and (B) L-Selectin (FITC), or the respective isotype control antibody. T
n=5), TgS100a8a9hep (Cd11b n=8; L-Selectin n=5) and Pos (n=3) samples wewere determined by flow cytometry on peripheral blood
neutrophils (Gr1+/Ly6G+ for Cd11b; Cd11b+/Ly6G+ for
L-Selectin) derived from Control and TgS100a8a9hep
animals (n≥5). Importantly, no difference in the mean
intensity was detectable for Cd11b and L-Selectin
surface expression, while Cd11b upregulation and L-
Selectin shedding was easily detectable upon TPA-
stimulation of isolated neutrophils (Figure 4A, B and
Additional file 5: Figure S5), suggesting an accelerated
mobilization but no further activation of neutrophils in
TgS100a8a9hep mice.
Altered expression of the chemokine Cxcl1 in the liver of
TgS100a8a9hep mice
As neutrophils have a relatively short life span in periph-
eral blood, continuous renewal by mobilization from the
bone marrow is mandatory [32]. This homeostatic re-
lease from the bone marrow is tightly regulated by an
equilibrium of retention and mobilization factors either
keeping the neutrophils in the hematopoietic cords of
the bone marrow or mediating the transition across the
sinusoidal endothelium into the circulating blood [32].
Recent studies demonstrated the importance of several
chemokines such as Cxcl1, Cxcl2, and Csf3 (G-Csf ) and
the interplay with their cognate receptors Cxcr2 and
Cxcr4 on the surface of neutrophils in the regulation of
homeostatic neutrophil mobilization [33,34]. Moreover,
the factors Csf1 (M-Csf) and Csf2 (Gm-Csf) have been
related to neutrophil mobilization under homeostasis as
well [32]. Although, several reports showed S100a8/a9-
mediated chemoattraction of neutrophils [14,16,24,26], a
direct involvement of transgenic proteins in neutrophil
mobilization in TgS100a8a9hep mice was unlikely as no
systemic difference in S100a8/a9 protein serum levels
was detected (Figure 1E). Consequently, we hypothesizedmice. Blood neutrophils (Gr1+/Ly-6G+ or Cd11b+/Gr1+) from Control
for 5 min (Pos) were stained with specific antibodies for (A) Cd11b
he mean fluorescence intensities from Control (Cd11b n=9; L-Selectin
re determined and depicted as means +SEM.
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the liver of TgS100a8a9hep mice induced the expression
of one or more factors, which in turn were able to medi-
ate neutrophil mobilization from the bone marrow. First,
we analyzed cDNA from livers of Control and
TgS100a8a9hep mice by qRT-PCR for the expression of
Csf1, Csf2, Csf3, Cxcl1, and Cxcl2. Transcripts of Csf2
and Csf3 were not detectable (data not shown), whereas
the expression of Cxcl2 and Csf1 revealed no significant
difference between TgS100a8a9hep and Control livers
(Figure 5A). Interestingly, Cxcl1 transcripts were signifi-
cantly upregulated in TgS100a8a9hep as compared to
Control mice (Figure 5A).
To address the question whether hepatocytes are the
source of increased Cxcl1 transcript levels in
TgS100a8a9hep mice, livers of Control and TgS100a8a9hep
mice (n=3 each) were perfused with collagenase and
the cell suspension was cultivated in vitro for 24 hoursFigure 5 Chemokine levels in liver, primary hepatocytes, and serum o
Cxcl1, Cxcl2 and Csf1 was determined by qRT-PCR analysis on liver cDNA fro
mean +SD. (B) Primary hepatocytes were isolated from Control and TgS100
Cxcl1, Cxcl2, Csf1 was measured by qRT-PCR on cDNA from primary hepato
triplicates and means are depicted +SD, students t-test, *p≤0.05. (C) Protein
TgS100a8a9hep (n≥4) mice were measured by ELISA. Mean +SD, students t-to obtain primary hepatocytes. One aliquot of the cell
suspension was directly taken after enzymatic digestion
and a significant increase in Cxcl1 transcript levels in
the liver of TgS100a8a9hep mice was confirmed by qRT-
PCR (Additional file 6: Figure S6A). Subsequent qRT-
PCR analysis with cDNA from primary hepatocytes,
which were cultured in vitro for 24 hours revealed a
strong expression in S100a8 and S100a9 transgenes in
TgS100a8a9hep hepatocytes and a significant increase in
the expression of Cxcl1 in TgS100a8a9hep as compared
to Control hepatocytes, whereas Cxcl2 and Csf1 were
not affected (Figure 5B and Additional file 6: Figure
S6B). These data strongly suggest that hepatocytes are
the main source of increased Cxcl1 transcription in the
liver of TgS100a8a9hep mice.
Finally, we analyzed serum and liver samples of Con-
trol and TgS100a8a9hep mice by enzyme-linked absorb-
ent immunoassays (ELISA) for Cxcl1, Cxcl2, and Csf3f Control and TgS100a8a9hep mice. (A) Relative expression of
m Control (n=6) and TgS100a8a9hep (n=9) mice and is depicted as
a8a9hep mice and cultivated in vitro for 24 hours. Relative expression of
cytes. Two biological replicates for each group were measured in
levels of Cxcl1, Cxcl2, and Csf3 in serum samples from Control and
test, *p≤0.05.
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measured in both groups, whereas only low amounts
were detected for Cxcl2 (Figure 5C). We found no major
difference in Cxcl2 and Csf3 protein levels, but in ac-
cordance with the qRT-PCR data, Cxcl1 protein levels
were significantly increased in TgS100a8a9hep as com-
pared to Control mice (Figure 5C and Additional file 7:
Figure S7).
Enhanced Cxcl1 expression and neutrophil enrichment in
TgS100a8a9hep mice depends on transgene expression
Control (Co) and TgS100a8a9hep (Tg) animals were trea-
ted either with (Tg +dox, Co +dox) or without (Tg -dox,
Co -dox) doxycycline-containing drinking water for
three weeks to investigate, whether the observed in-
crease in Cxcl1 levels and systemic enrichment of neu-
trophils critically depends on the presence of
hepatocyte-specific tgS100a8 and tgS100a9 expression in
adult mice. qRT-PCR analysis on livers from four ani-
mals per group, respectively, confirmed a significant in-
crease in Cxcl1 transcript levels in Tg -dox mice as
compared to Co -dox animals. While doxycycline treat-
ment had no impact on Cxcl1 expression in Co +dox
mice, the Cxcl1 transcript levels were reduced to basal
levels in Tg +dox mice upon doxycycline treatment
(Figure 6A). In line with reduced Cxcl1 expression, we
found a significant decreased in the amount of periph-
eral neutrophils in the blood of Tg +dox mice
(Figure 6B, Additional file 8: Figure S8), as measured by
FACS analysis and blood counts, accompanied by
reduced neutrophil numbers in liver sections of Tg +dox
as compared to Tg -dox littermates (Figure 6C). In
contrast, doxycycline treatment did neither affect neu-
trophil numbers nor the number of Cd11b+/Gr1+/Ly6G-
cells in Co +dox mice (Figure 6, data not shown).
Absolute numbers of neutrophils in blood counts
from Control and TgS100a8a9hep mice with and without
doxycycline treatment revealed similar results (Add-
itional file 8: Figure S8).
Taken together our data confirmed that the increase in
Cxcl1 expression, which is accompanied by systemic en-
richment of neutrophils in TgS100a8a9hep mice critically
depends on conditional S100a8 and S100a9 transgene
expression in the liver.
The p38 MAPK pathway is inhibited in TgS100a8a9hep
hepatocytes and represents a negative regulator of Cxcl1
expression
In order to unravel molecular mechanisms of transgene
induce Cxcl1 expression, we prepared protein lysate
from freshly isolated primary hepatocytes derived from
Control and TgS100a8a9hep liver. Western Blot analysis
revealed similar expression and phosphorylation of p65,
c-Jun, Stat3, and ERK1/2, but a substantial decrease inphospho-p38 protein levels was evident in TgS100a8a9hep
as compared to Control hepatocytes (Figure 7A). Densi-
tometric quantification of phosphorylated and total p38
protein levels confirmed a 50% reduced phosphoryl-
ation due to transgene expression (data not shown). To
further confirm the role of phosphorylated p38 as a
negative regulator for Cxcl1 expression, freshly isolated
wild type primary hepatocytes were treated with the
p38 MAPK-specific inhibitor SB203580 for 5 hr and
qRT-PCR analyses revealed a significant increase of
Cxcl1 transcript levels in hepatocytes with impaired
p38 MAPK activity as compared to DMSO treated cells
(Figure 7B). In contrast, Cxcl2 and Csf1 transcript levels
were significantly decreased upon p38 inhibition,
which is in line with our previous observation that
tgS100a8/a9 expression specifically induces Cxcl1 ex-
pression in hepatocytes from TgS100a8a9hep mice
(Figure 5B). In summary, these data demonstrate that
impaired p38 MAPK activity in the presence of
tgS100a8/a9 expression triggers a specific induction of
Cxcl1 expression in hepatocytes.
Discussion
A broad range of experimental studies demonstrate a dir-
ect link between S100a8/a9 protein expression and acute
and chronic inflammation as well as inflammation-
induced carcinogenesis [8]. In fact, S100a8/a9 is involved
in several steps of the inflammatory response including
leukocyte differentiation and chemoattraction, transen-
dothelial migration, activation of immune and epithelial
cells, and the induction of pro-inflammatory mediators
[7]. Thereby S100a8/a9 might promote an inflammatory
feed-forward loop, which facilitates the transition to a
chronic inflammation. An established chronic inflamma-
tion strongly increases the likelihood of pathologic condi-
tions such as tumor formation and is even considered as a
hallmark of carcinogenesis [35]. Indeed in vivo studies
with S100a9-/- animals highlighted a crucial role for
S100a8/a9 in the promotion of inflammation and
inflammation-induced carcinogenesis in models of antigen-
induced arthritis and colon carcinogenesis, respectively
[18,19]. However these studies focused on the role of
S100a8/a9 in the differentiation and function of myeloid-
derived S100a8/a9. In contrast, no causal connection of
epithelial-derived S100a8/a9 and the initiation and main-
tenance of a chronic inflammation and subsequent
tumor-development have been demonstrated yet.
In order to investigate the role of epithelial-derived
S100a8/a9 in liver homeostasis, we generated
TgS100a8a9hep mice with conditional and hepatocyte-
specific S100a8 and S100a9 expression. The initial
characterization revealed persistent transgene expression
in liver. Furthermore the conditional tgS100a8/a9 ex-
pression in TgS100a8a9hep mice was confirmed via
Figure 6 Measurement of neutrophil numbers and Cxcl1 expression in Control and TgS100a8a9hep mice treated with doxycycline.
Control (Co) and TgS100a8a9hep (Tg) mice were treated with (Co +dox, Tg +dox) or without (Co -dox, Tg -dox) doxycycline (10 μg/ml) containing
drinking water. (A) Relative expression of Cxcl1 was determined by qRT-PCR on liver cDNA. Mean +SD, students t-test, *p≤0.05, **p≤0.01, n.s. not
significant. (B) Peripheral blood cells were stained with specific antibodies for Cd11b (APC), Gr1 (PE) and Ly-6G (FITC) followed by flow cytometry
analysis. Box-plot shows the relative fold increase of Gr1+/Ly-6G+ population from all Cd11b+ cells in peripheral blood; Median, 25% and 75%
quartile (light grey boxes), students t-test, *p≤0.05. (C) IHC staining with Gr1-specific antibodies was performed on liver sections and
representative images (n=4 animals per group) are shown with red staining for positively stained cells and counterstaining with hematoxilin. Bars
represent 200 μm.
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was detected in purified whole liver lysates from
TgS100a8a9hep mice, whereas the serum levels of total
S100a8/a9 were unchanged in TgS100a8a9hep mice com-
pared to Controls. In summary the TgS100a8a9hep mice
showed conditional and hepatocyte-specific expression of
tgS100a8/a9 transcripts, which was not sufficient to reach
a systemic increase of total S100a8/a9. Interestingly, all
animal models, which were used so far to show S100a8/a9-dependent immune cell recruitment and activation ac-
companied by pathologic conditions were characterized
by a strong S100a8/a9 overexpression [14,16,23,24]. In
contrast, the use of the TgS100a8a9hep mouse model
enabled for the first time a detailed analysis of physio-
logical and pathophysiological alterations in settings of
low and locally restricted S100a8/a9 induction in vivo.
S100a8/a9 has been shown to act as a potent chemo-
attractant and activator for monocytes and neutrophils
Figure 7 Involvement of signaling pathways in Cxcl1 upregulation in hepatocytes. (A) Primary hepatocytes were isolated from Control and
TgS100a8a9hep mice (n=2). Expression of p65, c-Jun, Stat3, p38, ERK1/2, and the corresponding phosphorylated forms was monitored by Western
Blot analysis. (B) Primary hepatocytes were treated either with SB203580 or with (DMSO) for 5 h and relative expression of Cxcl1, Cxcl2, and Csf1
was determined by qRT-PCR; n=5, Mean +SD, students t-test, **p≤0.01.
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expected to induce pathologic changes affecting liver
homeostasis. However, TgS100a8a9hep mice showed nei-
ther obvious differences in liver architecture and liver
damage nor changes in the number of resident Kupffer
cells. Interestingly, TgS100a8a9hep animals developed a
significant enrichment of Gr1-positive immune cells in
the liver as compared to Control mice. Further
characterization showed that this immune cell subpopu-
lation was positive for endogenous S100a8 and S100a9
proteins and transcripts, and importantly, aged
TgS100a8a9hep animals exhibited a comparable enrich-
ment of this specific immune subpopulation, supporting
the existence of a constitutive signal in TgS100a8a9hep
mice, which leads to a sustained increase of these cells.
Of note, the Gr1-positive subpopulation did not infil-
trate into the liver parenchyma but rather accumulated
in the blood and therefore appeared in the sinusoids of
the liver. Therefore we hypothesized a systemic accumu-
lation of Gr1-positive cells in TgS100a8a9hep mice. In-
deed, qRT-PCR analysis revealed an elevation of
endogenous S100a8/a9 transcripts, which was used as a
surrogate marker for the affected subpopulation, also in
other perfused tissues including brain, kidney, and heart.
This further supported the hypothesis of a systemicenrichment in TgS100a8a9hep mice, which was further
confirmed by blood counts and flow cytometric analysis
on peripheral blood samples. Although spleen is a highly
perfused organ, it serves as marginating pool for granu-
locytes, ensuring rapid mobilization of innate immune
cells upon infection and inflammation to facilitate an
immediate inflammatory response [36]. Consequently,
the overall amount of S100a8/a9 is very high and the dif-
ference due to the enriched population in TgS100a8a9hep
mice was not detectable.
Neutrophils circulating in the blood stream under
healthy conditions, serve as first defense line against
pathogens, and represent key players in sterile inflamma-
tory diseases by secreting a plethora of different pro-
inflammatory mediators [37]. Since the TgS100a8a9hep
mice developed no obvious pathological phenotype over
time it was questioned whether the neutrophils were
fully activated. Indeed, flow cytometric analysis on neu-
trophils of TgS100a8a9hep mice revealed neither an in-
crease in Cd11b expression nor ectodomain shedding of
L-Selectin, which are well-known activation markers of
neutrophils [31,38]. Together, these data convincingly
show that the enriched neutrophils in the TgS100a8a9hep
mice are not activated, and additional signals are missing
to induce an acute and/or chronic inflammation.
Figure 8 Model of S100a8/a9-Cxcl1-mediated neutrophil
enrichment in TgS100a8a9hep mice. The S100a8/a9 protein
complex is produced in the liver of TgS100a8a9hep mice and induces
a specific expression of the neutrophil chemoattractant Cxcl1 in
hepatocytes, which in turn leads to an increased pool of Cxcl1
protein in the serum of transgenic mice. Consequently, Cxcl1
enhances the release of neutrophils from the bone marrow and
increases the number of circulating non-activated neutrophils, which
also appear in distant organs such as liver.
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directly act as a chemoattractant for neutrophils and
lead to tissue-specific recruitment but was also reported
as an activator of neutrophils [14,23]. Furthermore, a
causal role for S100a8 in inducing myeloid cell migration
has been demonstrated without further activation [39].
However TgS100a8a9hep mice showed a systemic enrich-
ment of neutrophils without activation and site-specific
recruitment. This argues for a so far unknown mechan-
ism of S100a8/a9, which might be only visible under
conditions when tgS100a8/a9 expression is locally
restricted to the liver without potent systemic accumula-
tion. Hence we assumed that a mechanism, which is
implicated in regulation of circulating neutrophils under
homeostasis, was affected in TgS100a8a9hep mice result-
ing in elevated neutrophil levels. The number of circulat-
ing neutrophils is mainly regulated via a constant release
from the bone marrow compartment. This homeostatic
release is realized either by Csf3, which is able to inter-
fere with the Cxcl12-Cxcr4 mediated neutrophil reten-
tion [33,34,38], or by Cxcl1 and Cxcl2, which directly act
as chemoattractants for neutrophils via Cxcr2 [40].
Moreover, experimental evidence suggests that other fac-
tors e.g. Csf1 and Csf2 might be involved in neutrophil
mobilization under homeostasis [40,41]. Interestingly,
only Cxcl1 was increased in the liver and serum of
TgS100a8a9hep compared to Control mice, whereas
other factors were either not detectable or were not
altered. Moreover, Cxcl1 was overexpressed in primary
hepatocytes isolated from TgS100a8a9hep mice, support-
ing that an increase in Cxcl1 expression is at least in
part mediated by hepatocytes.
In line with our findings, recent reports demonstrated
that administration of recombinant Cxcl1 in mice results
in a three- to four-fold increase in the number of circu-
lating neutrophils due to release from the bone marrow
[34,42]. Accordingly, transgenic mice overexpressing
Cxcl1 in different tissues showed elevated numbers of
circulating neutrophils [43]. It is worth mentioning that
also Cxcl1-induced neutrophils showed no signs of fur-
ther activation in terms of Cd11b upregulation and L-
Selectin shedding [31]. On the other hand mice deficient
for Cxcr2 displayed an abnormal retention of neutrophils
in the bone marrow whereas the numbers of circulating
neutrophils largely declined [33].
To finally prove the causal link between transgene ex-
pression and the Cxcl1 induction as well as the accumu-
lation of neutrophils in TgS100a8a9hep mice, the
transgene expression was repressed by doxycycline treat-
ment. Indeed, TgS100a8a9hep mice with repressed trans-
gene expression exhibited baseline Cxcl1 transcript
levels in the liver, accompanied by a normal number of
neutrophils in peripheral blood. These data supported
the assumption that the expression of Cxcl1 transcriptsis causally linked to tgS100a8/a9 expression in the liver
and that the accelerated mobilization of neutrophils
from bone marrow is mediated by the specific increased
of Cxcl1 expression in the liver of TgS100a8a9hep mice
(Figure 8).
The expression of Cxcl1 is regulated by several tran-
scription factors, including NF-κB [44], AP-1 [45], and
Stat3 [46], which facilitate a rapid activation upon in-
flammatory stimulation. S100a8/a9 expressed by hepato-
cytes in TgS100a8a9hep mice may be secreted in minor
amounts and act in an autocrine manner via binding to
Rage or Tlr4, both well established membrane receptors
for extracellular S100a8/a9 [19,47]. Engagement of these
receptors has been shown to induce relevant transcrip-
tion factors for induced Cxcl1 transcription as well as
their upstream signaling pathways, such as p38 and
ERK1/2 MAPKs [48-50]. Western Blot analysis of pri-
mary hepatocytes revealed a substantial decrease in acti-
vation of the p38 MAPK pathway whereas other
pathways were not altered. Inhibition of p38 activity was
shown previously by our group and others in situations
of intracellular S100a8/a9 expression [21,51]. In contrast,
extracellular S100a8/a9 rather lead to a positive regula-
tion of p38 [17,51]. Together with the finding that
S100a8/a9 serum levels are unchanged in TgS100a8a9hep
as compared to Control and increased Cxcl1 levels were
observed in isolated hepatocytes our results point to an
intracellular rather than an extracellular mode of action,
how S100a8/a9 mediated Cxcl1 induction. Finally, inhib-
ition of p38 MAPK lead to increased expression of Cxcl1
in primary hepatocytes by an as yet unknown mechan-
ism indicating a role of p38 as a negative regulator for
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stimuli.
Conclusion
TgS100a8a9hep mice with conditional and hepatocyte-
specific expression of S100a8 and S100a9 served as an
useful tool to unravel a so far unknown function of cal-
protectin on the mobilization of neutrophils. Our new
findings have a major impact on the current view, how
calprotectin may influence acute and chronic inflamma-
tion under pathological conditions. Ichikawa et al. [19]
demonstrated in a model of colitis-associated carcino-
genesis that myeloid-derived S100a8/a9 induces chemo-
kine expression by tumor cells, including Cxcl1, which
was associated with an accumulation of Cd11b+/Gr1+
immune cells. However, TgS100a8a9hep mice revealed a
neutrophil mobilization upon expression of S100a8/a9 in
non-transformed epithelial cells (Figure 8), and eluci-
dated a complete new aspect of the role played by cal-
protectin in epithelial cells: S100a8/a9 may support an
acute inflammatory response by increasing steady state
levels of circulating neutrophils and thereby help to re-
store tissue homeostasis. However, under settings of sus-
tained tissue damage the constitutive mobilization of
neutrophils by a S100a8/a9-Cxcl1-dependent mechanism
could enhance the risk for the development and main-
tenance of chronic inflammation.
Methods
Animals and animal work
Animals were maintained in a specific pathogen-free en-
vironment. All animal experiments were performed with
age-matched male mice. The procedures for performing
animal experiments were in accordance with the princi-
ples and guidelines of the Arbeitsgemeinschaft der
Tierschutzbeauftragten in Baden-Württemberg and were
approved by the German Regional Council in Karlsruhe.
TALap1 mice were described previously [25]. In order
to generate the TetOa8a9 mouse line, a bidirectional
Tet-inducible expression plasmid was cloned from the
parental pBi-L (Clontech Laboratories) encoding
S100a8-myc/his and S100a9-myc/his fusion constructs
driven by Tet-responsive promoter. The linearized pBi-
S100a8a9 construct was injected into blastocytes of
C57B1/6 mice. Genomic integration was determined by
Southern Blot analysis.
For the analysis TALap1 and TetOa8a9 single trans-
genic mice served as Control animals. For doxycycline
treatment, 6 to 8 week-old animals received 10 μg/ml
doxycycline 5% sucrose containing drinking water ad
libitum for a period of 3 weeks. Primary mouse hepato-
cytes were isolated and cultured as described [52].
Briefly, 8 week-old mice were anesthetized by intraperi-
toneal injection of 5 mg/100 mg body weight 10%ketamine hydrochloride and 1 mg/100 mg body weight
2% xylazine hydrochloride. After opening the abdominal
cavity, the liver was perfused at 37°C with EGTA buffer
(0.6% Glucose (w/v), 105 mM NaCl, 2.4 mM KCl, 1.2
mM KH2PO4, 26 mM Hepes, 490 μM L-Glutamine, 512
μM EGTA, 15% (v/v) amino acid solution, pH 8.3) via
the portal vein for 5 min and subsequently for 5 min
with Collagenase buffer (0.6% Glucose (w/v), 105 mM
NaCl, 2.3 mM KCl, 1.2 mM KH2PO4, 25 mM Hepes,
490 μM L-Glutamine, 5.3 mM CaCl2, 12% (v/v) amino
acid solution, 365 μg/ml collagenase type I-A, pH 8.3)
until disintegration of the liver structure was observed.
The liver capsule was removed, and the cell suspension
was filtered through a 100 μm mesh. Cells were washed
and, subsequently, viability of cells was determined by
trypan blue staining. Two million living cells were
seeded on collagen type I-coated 6 cm dishes and har-
vested after 24 hr. For in vitro inhibition of p38 MAPK,
freshly isolated primary hepatocytes were treated with
SB203580 (10 μM) or its solvent (DMSO) and harvested
after 5 hr.
Protein isolation and Western blot analysis
Preparation of whole cell extracts was done with radio-
immunoprecipitation assay buffer (50 mM Tris-HCl pH
8.0, 150 mM NaCl, 0.1% SDS, 0.5% (v/v) sodium deoxyl-
cholate, 1% (v/v) NP-40, proteinase inhibitor cocktail),
and purification of Myc-tagged transgenic S100a8/a9
was performed with mammalian cMyc-tag/Co-IP Kit
(Pierce) according to the manufacturer’s instructions.
Proteins were separated on a 15% SDS-polyacrylamide
gel in SDS-sample buffer, transferred to nitrocellulose
membrane (Optitran BA-S83) and incubated with spe-
cific primary and HRP-labeled secondary antibodies
(DakoCytomation). The blots were developed using the
Classic E.O.S. developer (Agfa). Primary antibodies are
listed in Additional file 9 (Table S1).
Reagents
ELISAs for Cxc11, Cxcl2, G-Csf (all from R&D Systems),
and S100A8/A9 (Immundiagnostik AG) were performed
according to the manufacturer’s instructions.
Immunohistochemistry and tissue staining
IHC analysis on paraffin sections was performed accord-
ing to the manufacturer’s instructions (Vector Labora-
tories), and sections were counterstained with
hematoxylin. Primary and secondary antibodies are listed
in Additional file 9 (Table S1). Stained tissue sections
were visualized and photographed using a Leica DMLB
microscope and Olympus XC50 camera at a magnitude
of 100x. Representative pictures for each genotype are
shown.
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chain reaction
Total RNA extraction was performed according to the
manufacturer`s instructions using peqGOLD RNAPure
(PeqLab Biotechnology). RNA was reverse transcribed
using RevertAid H Minus-MuLV RT (Fermentas) and
oligo-dT primers, followed by standard qRT-PCR per-
formed on a detection system (StepOnePlus™; Applied
Biosystems) using the Power SYBRW Green PCR Master
Mix (Applied Biosystems). Quantitative real-time
polymerase chain reaction (qRT-PCR) analysis was
performed as described previously [53]. Primers used for
qRT-PCR analysis are listed in Additional file 10 (Table S2).
Target gene cycle of threshold values were normalized to
the corresponding cycle of threshold values of Hprt using
the change in cycle of threshold method.
Preparation of blood samples and flow cytometry
For detection of immune subpopulations in peripheral
blood, whole blood samples were mixed with EDTA
(final 5 mM), subjected to erythrocyte lysis (ACK buffer,
Lonza) and subsequently blockade of Fc-receptors (anti-
Cd16/32, eBioscience). Staining was performed at 4°C
for 30 min and cells were determined by flow cytometry
analysis in FACSCalibur (BD Bioscience) using the soft-
ware FlowJo (Tree Star, Inc.). Antibodies are listed in
Additional file 9 (Table S1). As positive control for
Cd11b upregulation and L-Selectin shedding, peripheral
blood cells were treated with 10 μg/ml TPA for 5 min
and stained as described.
Digital images and statistical analysis
Digital images were elaborated using Photoshop CS3
(Adobe); the luminosity of brightest and dimmest pixel
in each channel were adjusted to obtain the best visual
reproduction, taking care to maintain linearity in the
brightness scale. Error bars represent SD except were
indicated. Statistical evaluation of obtained data was per-
formed with SigmaPlot 11.0 (Systat Software Inc.).
Additional files
Additional file 1: Figure S1. TgS100a8 and tgS100a9 expression in
TgS100a8a9hep mice. Expression of tgS100a8 and tgS100a9 were analysed
by qRT-PCR with (A) cDNA of different tissues (liver, lymph nodes, and
bone marrow) from 8 weeks old TgS100a8a9hep mice (n=3) or with (B)
liver cDNA from two (n=5) and six (n=3) month old TgS100a8a9hep mice;
values were normalized to age-matched Control animals; mean, +SD.
Additional file 2: Figure S2. Analysis of additional parameters of
inflammation and liver damage in TgS100a8a9hep mice. (A) ALT and (B)
AST serum levels in 8 weeks old Control and TgS100a8a9hep mice (n=4).
Mdr2-/- mice served as positive control; mean, +SD. (C) Liver sections
from Control and TgS100a8a9hep mice were stained by IHC with specific
antibodies for HNE adducts. Liver sections from Mdr2-/- mice served as
positive control for the staining. Representative images from at least n=3
mice are shown with red staining for HNE and counterstaining withhematoxylin. Bar represent 200 μm. (D) Relative levels of endogenous
S100a8 and S100a9 transcripts was measured by qRT-PCR with liver cDNA
from Control (n=9) and TgS100a8a9hep (n=10) mice; mean, +SD, students
t-test, *p≤0.05.
Additional file 3: Figure S3. Histological and immunohistochemical
characterization of six month old TgS100a8a9hep mice. Liver sections from
six month old Control and TgS100a8a9hep mice were stained with
hematoxylin and eosin (HE) or by IHC with a specific antibody for
granulocytes (Gr1). Representative images are shown with red staining
for Gr1 (n=2 mice per group), and counterstaining with hematoxylin. Bars
represent 200 μm.
Additional file 4: Figure S4. Systemic enrichment of neutrophils in
TgS100a8a9hep mice. (A) Relative expression of endogenous S100a9
transcripts was determined by qRT-PCR using cDNA from different tissues
of Control (n=3) and TgS100a8a9hep (n=4) mice. Mean +SD, students t-
test, *p≤0.05, **p≤0.01, n.s. not significant. (B) Absolute number of
neutrophils in peripheral blood from Control and TgS100a8a9hep mice
(n=4) as measured by means of blood counts. (C-E) Peripheral blood
from Control mice (n=8) was subjected to tri-color staining using
antibodies against Cd11b (APC), Ly-6G (FITC), and Gr1 (PE) or Ly-6C (PE),
respectively. Representative images of either (C) Gr1/Ly-6G or (D) Ly-6C/
Ly-6G populations are shown. (E) Graph shows the total percentage of
Gr1+/Ly-6G+ cells and Ly-6C+/Ly-6G+ cells from all Cd11b+ cells in
peripheral blood; +SD.
Additional file 5: Figure S5. Molecular markers of neutrophil activation
in TgS100a8a9hep mice. Blood neutrophils (Gr1+/Ly6G+ or Cd11b+/Ly6G+)
from Control and TgS100a8a9hep mice were stained with specific
antibodies for Cd11b (APC) and L-Selectin (PE), or the respective isotype
control antibody. Representative histograms of Cd11b (A) and L-Selectin
(B) stainings are shown for Control (red) and TgS100a8a9hep (green) mice,
including the staining with their respective isotype control (black).
Additional file 6: Figure S6. Cxcl1 and tgS100a8/a9 expression in
primary hepatocytes from Control and TgS100a8a9hep mice. (A) Relative
Cxcl1 transcript levels was determined by qRT-PCR analysis with cDNA
from cell suspension derived from collagenase perfused livers of Control
and TgS100a8a9hep mice. (B) Primary hepatocytes were cultivated in vitro
for 24 hours and relative levels of tgS100a8 and tgS100a9 transcripts were
measured by qRT-PCR. Two biological replicates for each group were
measured in triplicates and means are depicted +SD, students t-test,
**p≤0.01.
Additional file 7: Figure S7. Cxcl1 protein expression in liver lysates
from Control and TgS100a8a9hep mice. Protein levels of Cxcl1 in liver
lysate from Control and TgS100a8a9hep mice (n=4) were measured by
ELISA. Mean +SD, students t-test, **p≤0.01.
Additional file 8: Figure S8. Peripheral neutrophils in Control and
TgS100a8a9hep mice treated with doxycycline. Control (Co) and
TgS100a8a9hep (Tg) mice were treated with (Co +dox, Tg +dox) or without
(Co -dox, Tg -dox) doxycycline (10 μg/ml) containing drinking water.
Peripheral blood neutrophils were measured by means of blood counts
and depicted as absolute numbers. Box-plot shows median, 25 % and 75
% quartile (light grey box).
Additional file 9: Table S1. Antibodies used for IHC, Western blotting,
and flow cytometry.
Additional file 10: Table S2. Primer pairs used for qRT-PCR analysis.
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